Institut Paoli-calmettes

This study is testing whether adding the immunotherapy drug pembrolizumab to standard chemotherapy before surgery helps eliminate aggressive inflammatory breast cancer tumors. It involves 52 adults with a specific type of breast cancer (HER2-negative) that has not spread. The mai…

This study aims to understand why some advanced breast cancers respond well to standard hormone therapy while others become resistant. Researchers will analyze tumor samples from 115 patients before and after treatment to identify genetic markers that predict treatment success. T…

This study aims to identify molecular patterns in tissue samples that might predict how gynecological cancers behave. Researchers will collect samples from 300 women with suspected ovarian, cervical, or endometrial cancer. The goal is to link these molecular findings to the patie…

This study aims to determine if measuring two specific proteins (MMP2 and MMP9) in blood can help predict how well patients with metastatic kidney cancer will respond to anti-angiogenic drugs like Sunitinib or Pazopanib. Researchers will compare protein levels in 50 patients rece…